Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |